Stockholders’ Equity (Details Narrative) - USD ($) $ / shares in Units, $ in Thousands |
12 Months Ended | |
|---|---|---|
Oct. 30, 2025 |
Dec. 31, 2024 |
|
| Subsidiary, Sale of Stock [Line Items] | ||
| Value of shares | $ 13,591 | |
| Fair value of warrants issued | $ 1,000 | |
| Pre-Funded Warrants [Member] | ||
| Subsidiary, Sale of Stock [Line Items] | ||
| Number of warrant issued | 2,000 | |
| Underwriters [Member] | ||
| Subsidiary, Sale of Stock [Line Items] | ||
| Number of warrant issued | 9,000 | |
| Common Stock [Member] | ||
| Subsidiary, Sale of Stock [Line Items] | ||
| Value of shares | ||
| Warrant [Member] | ||
| Subsidiary, Sale of Stock [Line Items] | ||
| Weighted average exercise price of warrants | $ 140.88 | |
| ATM Agreement [Member] | Common Stock [Member] | ||
| Subsidiary, Sale of Stock [Line Items] | ||
| Value of shares | $ 50,000 |
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|